Toxicity Management Workshop

Friday, March 31, 2017, 8:00 AM - 6:00 PM ET

sitc_log_color.pngThe durable responses and generally well-tolerated side effects characteristic of cancer immunotherapy agents, particularly immune checkpoint inhibitors, have led to an influx of approvals for a growing number of malignancies. However, as more patients turn to immune-based treatments, and as the potential to improve patient outcomes using combination immunotherapy grows, knowledge about how to recognize and manage the associated toxicities must be disseminated broadly and rapidly.  

There is an urgent need among practicing oncologists and nurses for treatment algorithms that guide management of immunotherapy-related toxicities. Similarly, standardized templates for reporting adverse events in clinical trials are needed in order to facilitate monitoring and reporting of toxicities, an effort which is considered a high priority by the FDA. To this end, SITC is taking the lead to convene a one-day Toxicity Management Workshop on Friday, March 31, 2017, in Washington, D.C. 

The workshop will address two pressing needs for the advancement of the field:

  1. Creating treatment algorithms for managing immunotherapy-related toxicities
  2. Developing standardized templates for adverse event management in protocols for clinical trials

The workshop will be a multi-stakeholder effort of 200 thought leaders from government, academia, industry, scientific organizations and other related entities. These stakeholders want to move quickly and convene to address the growing need for standardization to provide better treatments and ultimately, improve patient outcomes. Workshop outcomes will result in a publication.

Register now to participate in the consensus-building workshop.

Organizers

Marc S. Ernstoff, MD – Roswell Park Cancer Institute
Igor Puzanov, MD, MSCI, FACP – Roswell Park Cancer Institute
Caroline Robert, MD, PhD – Institut Gustave Roussy

Steering Committee

Adi Diab, MD – University of Texas MD Anderson Cancer Center
Howard L. Kaufman, MD, FACS – Rutgers Cancer Institute of New Jersey
Theodore F. Logan, MD – Indiana University Simon Cancer Center
Jason J. Luke, MD, FACP – University of Chicago

Agenda

8 – 8:10 a.m.               SITC Welcome
                                     Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey

Program Welcome & Introduction           
Marc S. Ernstoff, MD – Roswell Park Cancer Institute

Session I: Common Toxicity Management Discussion
             Goals:    (1) Develop Treatment Algorithms for Managing Toxicity
                            (2) Build Consensus Language for Toxicity Management in Clinical Trial Protocols

8:10 – 8:15 a.m.    Body System Break-Outs
                                      Dermatology
                                      Endocrinology
                                      Gastroenterology
                                      Pulmonary
                                      Rheumatology

8:15 – 10 a.m.       Treatment Algorithm Development for Toxicity Management

10 – 11 a.m.          Consensus Language Building for Clinical Trial Protocols

11 – 11:15 a.m.        Break

11:15 a.m. – 1 p.m.       Group Reporting and Consensus Building

Session II: Rare Toxicity Management Discussion
             Goals:    (1) Develop Treatment Algorithms for Managing Toxicity
                            (2) Build Consensus Language for Toxicity Management in Clinical Trial Protocols

1 – 1:30 p.m.         Working Lunch

1 – 1:15 p.m.        Body System Break-Outs
                                      Cardiology
                                      Hematology
                                      Neonatology
                                      Nephrology
                                      Neurology
                                      Ophthalmology

1:15 – 4 p.m.        Treatment Algorithm Development for Toxicity Management 

4 – 4:15 p.m.         Break

4:15 – 5 p.m.         Consensus Language Building for Clinical Trial Protocols

5 – 5:55 p.m.         Group Reporting and Consensus Building

5:55 – 6 p.m.         Closing Remarks
                                      Igor Puzanov, MD, MSCI, FACP – Roswell Park Cancer Institute

Support

The Toxicity Management Workshop is supported in part by grants from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb and Merck & Co., Inc.

Location

Washington Marriott at Metro Center
775 12th Street NW
Washington, DC

Tags

  • Cancer Research
  • Clinical Trials
  • CE
  • No CE Offered
  • Modality
  • In person Event
  • Source
  • Collaboration
  • Therapies
  • Adverse Events
  • Immune Checkpoint Inhibitors
  • Toxicities
  • User Type
  • Industry
  • Nurse
  • Oncologist
  • Year
  • 2017